Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Aug;84(2):348-56.
doi: 10.1189/jlb.0308149. Epub 2008 May 8.

Interleukin 21: a cytokine/cytokine receptor system that has come of age

Affiliations
Review

Interleukin 21: a cytokine/cytokine receptor system that has come of age

Warren J Leonard et al. J Leukoc Biol. 2008 Aug.

Abstract

Interleukin-21 (IL-21) and its receptor represent the sixth cytokine system whose actions were recognized to require the common cytokine receptor gamma chain. IL-21 is produced by activated CD4+ T cells, natural killer T cells, and follicular T helper cells and has actions on a range of lymphohematopoietic lineages. Among its many effects, IL-21 serves a critical role for immunoglobulin production and terminal B cell differentiation, acts as a T cell comitogen and can drive the expansion of CD8+ T cells, can negatively regulate dendritic cell function and plays an essential role in the differentiation of Th17 cells. Importantly, IL-21 is implicated in the pathogenesis of autoimmunity and exhibits potent actions as an antitumor agent. The ability to regulate and manipulate the actions of IL-21, therefore, has important implications for immunoregulation and the therapy of human disease.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Cytokines (IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21) whose receptors share the common cytokine receptor γ subunit, γc. Each of these cytokine receptors also contains one or two more distinctive receptor subunits.
Fig. 2.
Fig. 2.
The mouse IL-21 receptor (IL-21R) contains six tyrosine residues in its cytoplasmic domain. Y510 is within a consensus Stat3-bibding motif, YXXQ (boxed). TM, transmembrane domain.
Fig. 3.
Fig. 3.
A model for IL-21R signaling. IL-21 can activate at least three signaling pathways: Jak-STAT, MAPK, and PI 3-kinase pathways.
Fig. 4.
Fig. 4.
Schematic of the sequential roles of IL-6, IL-21, and IL-23 in Th17 lineage differentiation. IL-6 helps to initiate Th17 differentiation, and via Stat3 induces expression of IL-21 and IL-21R. IL-21 can then induce IL-23R expression, and IL-23 can then act. This overall cytokine cascade then can result in stable Th17 differentiation.
Fig. 5.
Fig. 5.
Schematic showing the production of IL-21 by activated CD4+ T cells including follicular helper T (TFM) cell and natural killer T (NKT) cells and its action on a large array of target cells. Collectively, IL-21 can exert antitumor activity and additionally has effects in inflammation, autoimmunity, and allergic diseases. DC, Dentritic cells; MΦ, macrophages; EC, epithelial cells; Kera., Keratinocytes.

Similar articles

Cited by

References

    1. Ozaki K, Kikly K, Michalovich D, Young P R, Leonard W J. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA. 2000;97:11439–11444. - PMC - PubMed
    1. Parrish-Novak J, Dillon S R, Nelson A, Hammond A, Sprecher C, Gross J A, Johnston J, Madden K, Xu W, West J. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature. 2000;408:57–63. - PubMed
    1. Jin H, Carrio R, Yu A, Malek T R. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J Immunol. 2004;173:657–665. - PubMed
    1. Noguchi M, Yi H, Rosenblatt H M, Filipovich A H, Adelstein S, Modi W S, McBride O W, Leonard W J. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993;73:147–157. - PubMed
    1. Leonard W J. Cytokines and immunodeficiency diseases. Nat Rev Immunol. 2001;1:200–208. - PubMed

Publication types